LGMar 2, 2017Code
MoleculeNet: A Benchmark for Molecular Machine LearningZhenqin Wu, Bharath Ramsundar, Evan N. Feinberg et al.
Molecular machine learning has been maturing rapidly over the last few years. Improved methods and the presence of larger datasets have enabled machine learning algorithms to make increasingly accurate predictions about molecular properties. However, algorithmic progress has been limited due to the lack of a standard benchmark to compare the efficacy of proposed methods; most new algorithms are benchmarked on different datasets making it challenging to gauge the quality of proposed methods. This work introduces MoleculeNet, a large scale benchmark for molecular machine learning. MoleculeNet curates multiple public datasets, establishes metrics for evaluation, and offers high quality open-source implementations of multiple previously proposed molecular featurization and learning algorithms (released as part of the DeepChem open source library). MoleculeNet benchmarks demonstrate that learnable representations are powerful tools for molecular machine learning and broadly offer the best performance. However, this result comes with caveats. Learnable representations still struggle to deal with complex tasks under data scarcity and highly imbalanced classification. For quantum mechanical and biophysical datasets, the use of physics-aware featurizations can be more important than choice of particular learning algorithm.
LGNov 10, 2016Code
Low Data Drug Discovery with One-shot LearningHan Altae-Tran, Bharath Ramsundar, Aneesh S. Pappu et al.
Recent advances in machine learning have made significant contributions to drug discovery. Deep neural networks in particular have been demonstrated to provide significant boosts in predictive power when inferring the properties and activities of small-molecule compounds. However, the applicability of these techniques has been limited by the requirement for large amounts of training data. In this work, we demonstrate how one-shot learning can be used to significantly lower the amounts of data required to make meaningful predictions in drug discovery applications. We introduce a new architecture, the residual LSTM embedding, that, when combined with graph convolutional neural networks, significantly improves the ability to learn meaningful distance metrics over small-molecules. We open source all models introduced in this work as part of DeepChem, an open-source framework for deep-learning in drug discovery.
LGMay 29, 2019
Strategies for Pre-training Graph Neural NetworksWeihua Hu, Bowen Liu, Joseph Gomes et al.
Many applications of machine learning require a model to make accurate pre-dictions on test examples that are distributionally different from training ones, while task-specific labels are scarce during training. An effective approach to this challenge is to pre-train a model on related tasks where data is abundant, and then fine-tune it on a downstream task of interest. While pre-training has been effective in many language and vision domains, it remains an open question how to effectively use pre-training on graph datasets. In this paper, we develop a new strategy and self-supervised methods for pre-training Graph Neural Networks (GNNs). The key to the success of our strategy is to pre-train an expressive GNN at the level of individual nodes as well as entire graphs so that the GNN can learn useful local and global representations simultaneously. We systematically study pre-training on multiple graph classification datasets. We find that naive strategies, which pre-train GNNs at the level of either entire graphs or individual nodes, give limited improvement and can even lead to negative transfer on many downstream tasks. In contrast, our strategy avoids negative transfer and improves generalization significantly across downstream tasks, leading up to 9.4% absolute improvements in ROC-AUC over non-pre-trained models and achieving state-of-the-art performance for molecular property prediction and protein function prediction.
LGJul 24, 2018
Improved Training with Curriculum GANsRishi Sharma, Shane Barratt, Stefano Ermon et al.
In this paper we introduce Curriculum GANs, a curriculum learning strategy for training Generative Adversarial Networks that increases the strength of the discriminator over the course of training, thereby making the learning task progressively more difficult for the generator. We demonstrate that this strategy is key to obtaining state-of-the-art results in image generation. We also show evidence that this strategy may be broadly applicable to improving GAN training in other data modalities.
MLJul 24, 2018
Weakly-Supervised Deep Learning of Heat Transport via Physics Informed LossRishi Sharma, Amir Barati Farimani, Joe Gomes et al.
In typical machine learning tasks and applications, it is necessary to obtain or create large labeled datasets in order to to achieve high performance. Unfortunately, large labeled datasets are not always available and can be expensive to source, creating a bottleneck towards more widely applicable machine learning. The paradigm of weak supervision offers an alternative that allows for integration of domain-specific knowledge by enforcing constraints that a correct solution to the learning problem will obey over the output space. In this work, we explore the application of this paradigm to 2-D physical systems governed by non-linear differential equations. We demonstrate that knowledge of the partial differential equations governing a system can be encoded into the loss function of a neural network via an appropriately chosen convolutional kernel. We demonstrate this by showing that the steady-state solution to the 2-D heat equation can be learned directly from initial conditions by a convolutional neural network, in the absence of labeled training data. We also extend recent work in the progressive growing of fully convolutional networks to achieve high accuracy (< 1.5% error) at multiple scales of the heat-flow problem, including at the very large scale (1024x1024). Finally, we demonstrate that this method can be used to speed up exact calculation of the solution to the differential equations via finite difference.
LGJun 7, 2018
Graph Convolutional Policy Network for Goal-Directed Molecular Graph GenerationJiaxuan You, Bowen Liu, Rex Ying et al.
Generating novel graph structures that optimize given objectives while obeying some given underlying rules is fundamental for chemistry, biology and social science research. This is especially important in the task of molecular graph generation, whose goal is to discover novel molecules with desired properties such as drug-likeness and synthetic accessibility, while obeying physical laws such as chemical valency. However, designing models to find molecules that optimize desired properties while incorporating highly complex and non-differentiable rules remains to be a challenging task. Here we propose Graph Convolutional Policy Network (GCPN), a general graph convolutional network based model for goal-directed graph generation through reinforcement learning. The model is trained to optimize domain-specific rewards and adversarial loss through policy gradient, and acts in an environment that incorporates domain-specific rules. Experimental results show that GCPN can achieve 61% improvement on chemical property optimization over state-of-the-art baselines while resembling known molecules, and achieve 184% improvement on the constrained property optimization task.
LGJun 6, 2017
Retrosynthetic reaction prediction using neural sequence-to-sequence modelsBowen Liu, Bharath Ramsundar, Prasad Kawthekar et al.
We describe a fully data driven model that learns to perform a retrosynthetic reaction prediction task, which is treated as a sequence-to-sequence mapping problem. The end-to-end trained model has an encoder-decoder architecture that consists of two recurrent neural networks, which has previously shown great success in solving other sequence-to-sequence prediction tasks such as machine translation. The model is trained on 50,000 experimental reaction examples from the United States patent literature, which span 10 broad reaction types that are commonly used by medicinal chemists. We find that our model performs comparably with a rule-based expert system baseline model, and also overcomes certain limitations associated with rule-based expert systems and with any machine learning approach that contains a rule-based expert system component. Our model provides an important first step towards solving the challenging problem of computational retrosynthetic analysis.
MLJun 28, 2016
Modeling Industrial ADMET Data with Multitask NetworksSteven Kearnes, Brian Goldman, Vijay Pande
Deep learning methods such as multitask neural networks have recently been applied to ligand-based virtual screening and other drug discovery applications. Using a set of industrial ADMET datasets, we compare neural networks to standard baseline models and analyze multitask learning effects with both random cross-validation and a more relevant temporal validation scheme. We confirm that multitask learning can provide modest benefits over single-task models and show that smaller datasets tend to benefit more than larger datasets from multitask learning. Additionally, we find that adding massive amounts of side information is not guaranteed to improve performance relative to simpler multitask learning. Our results emphasize that multitask effects are highly dataset-dependent, suggesting the use of dataset-specific models to maximize overall performance.
MLJun 6, 2016
ROCS-Derived Features for Virtual ScreeningSteven Kearnes, Vijay Pande
Rapid overlay of chemical structures (ROCS) is a standard tool for the calculation of 3D shape and chemical ("color") similarity. ROCS uses unweighted sums to combine many aspects of similarity, yielding parameter-free models for virtual screening. In this report, we decompose the ROCS color force field into "color components" and "color atom overlaps", novel color similarity features that can be weighted in a system-specific manner by machine learning algorithms. In cross-validation experiments, these additional features significantly improve virtual screening performance (ROC AUC scores) relative to standard ROCS.
MLMar 2, 2016
Molecular Graph Convolutions: Moving Beyond FingerprintsSteven Kearnes, Kevin McCloskey, Marc Berndl et al.
Molecular "fingerprints" encoding structural information are the workhorse of cheminformatics and machine learning in drug discovery applications. However, fingerprint representations necessarily emphasize particular aspects of the molecular structure while ignoring others, rather than allowing the model to make data-driven decisions. We describe molecular "graph convolutions", a machine learning architecture for learning from undirected graphs, specifically small molecules. Graph convolutions use a simple encoding of the molecular graph---atoms, bonds, distances, etc.---which allows the model to take greater advantage of information in the graph structure. Although graph convolutions do not outperform all fingerprint-based methods, they (along with other graph-based methods) represent a new paradigm in ligand-based virtual screening with exciting opportunities for future improvement.
MLFeb 6, 2015
Massively Multitask Networks for Drug DiscoveryBharath Ramsundar, Steven Kearnes, Patrick Riley et al.
Massively multitask neural architectures provide a learning framework for drug discovery that synthesizes information from many distinct biological sources. To train these architectures at scale, we gather large amounts of data from public sources to create a dataset of nearly 40 million measurements across more than 200 biological targets. We investigate several aspects of the multitask framework by performing a series of empirical studies and obtain some interesting results: (1) massively multitask networks obtain predictive accuracies significantly better than single-task methods, (2) the predictive power of multitask networks improves as additional tasks and data are added, (3) the total amount of data and the total number of tasks both contribute significantly to multitask improvement, and (4) multitask networks afford limited transferability to tasks not in the training set. Our results underscore the need for greater data sharing and further algorithmic innovation to accelerate the drug discovery process.